Multilevel Analysis of Zero-Dose Children in Sub-Saharan Africa: A Three Delays Model Study

Charles S Wiysonge1, Muhammed M B Uthman2, Duduzile Ndwandwe1

  • 1Cochrane South Africa, South African Medical Research Council, Francie van Zijl Drive, Parrow Valley, Cape Town 7501, South Africa.

Vaccines
|September 27, 2025
PubMed

Insights

Zero-dose children in sub-Saharan Africa are most common among disadvantaged groups, with maternal health-seeking behavior being the key predictor. Policy should integrate antenatal care with vaccination and remove financial barriers.

Area of Science:

  • Public Health
  • Global Health
  • Pediatrics

Background:

  • Zero-dose children pose a significant barrier to universal immunization in sub-Saharan Africa.
  • The Three Delays Model provides a framework for understanding factors contributing to zero-dose status.

Purpose of the Study:

  • To examine multilevel factors associated with zero-dose children in sub-Saharan Africa.
  • To identify individual, community, and country-level determinants of zero-dose status.

Main Methods:

  • Analysis of demographic and health survey data from 30,500 children (12-23 months) across 28 sub-Saharan African countries (2015-2024).
  • Definition of zero-dose status as no diphtheria-tetanus-pertussis vaccine first dose.
  • Application of multilevel logistic regression to identify determinants.

Main Results:

  • Overall zero-dose prevalence was 12.19%, with significant variation across countries.
  • Poor maternal health-seeking behavior (OR 12.00) was the strongest predictor.
  • Paternal education, maternal empowerment (decision-making, financial barriers, media access), community literacy, and national health expenditure were significant factors.

Conclusions:

  • Zero-dose children are concentrated in disadvantaged populations, highlighting the critical role of maternal health-seeking behavior.
  • Policy recommendations include integrating antenatal care with vaccination, targeting high-parity mothers, and increasing national health expenditure.
Abstract

Related Concept Videos

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
292
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
249
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
210
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
219